CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President & Head of R&D acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Tech Operations Officer acquired 40,000 shares (grant or award)
- 4 Grant or award COO, CLO, Compliance Officer acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 30,000 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Planned sale Chief Executive Officer sold 23,429 shares at $10.92 ($255,746)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Tech Operations Officer sold 10,366 shares at $11.16 ($115,638)
- 4 Open-market sale COO, CLO, Compliance Officer sold 8,391 shares at $11.16 ($93,606)
- 4 Open-market sale Chief Medical Officer sold 1,100 shares at $11.16 ($12,271)
Page 2 of 12 · 234 filings